The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes.
Gabriele De MarcoPhilip HelliwellDennis McGonaglePaul EmeryLaura C CoatesElizabeth M A HensorHelena Marzo-OrtegaPublished in: BMC musculoskeletal disorders (2017)
EudraCT 2013-004122-28 . 24/09/2013.